-
Ono Pharmaceutical Secures Deal to Acquire Deciphera Pharmaceuticals for USD 2.4 Billion
•
Japan-based Ono Pharmaceutical Co., Ltd (TYO: 4528) has announced that it has reached an agreement to fully acquire US-based Deciphera Pharmaceuticals Inc. (Nasdaq: DCPH). According to Ono’s press release, the acquisition will involve Ono purchasing all outstanding shares of Deciphera for USD 25.60 per share in cash, which values the…
-
China’s CDE Proposes Removal of Ambroxol Inhalation Solution and Four Other Drugs
•
The Center for Drug Evaluation has issued a notification concerning the Chemical Generic Drug Reference Preparation Adjustment List, inviting public feedback on the draft proposal before the deadline of October 7, 2023. The list proposes the removal of Ambroxol inhalable solution and four other varieties, totaling nine specifications. Specific Drugs…
